v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common stock
Additional Paid In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 30 $ 20,296,507 $ 2,419 $ (15,264,691) $ 5,034,265
Balance (in Shares) at Dec. 31, 2024 298,964        
Accumulated other comprehensive gain (loss) - short-term debt investments 8,285 8,285
Net loss   (1,031,437) (1,031,437)
Balance at Mar. 31, 2025 $ 30 20,296,507 10,704 (16,296,128) 4,011,113
Balance (in Shares) at Mar. 31, 2025 298,964        
Balance at Dec. 31, 2024 $ 30 20,296,507 2,419 (15,264,691) 5,034,265
Balance (in Shares) at Dec. 31, 2024 298,964        
Net loss         (2,235,730)
Balance at Jun. 30, 2025 $ 58 22,407,882 9,564 (17,500,421) 4,917,083
Balance (in Shares) at Jun. 30, 2025 576,742        
Balance at Mar. 31, 2025 $ 30 20,296,507 10,704 (16,296,128) 4,011,113
Balance (in Shares) at Mar. 31, 2025 298,964        
Sale of common stock, net of offering costs and expenses of $406,044 $ 18 1,227,939 1,227,957
Sale of common stock, net of offering costs and expenses of $406,044 (in Shares) 181,556        
Sale of pre-funded warrants 365,940 365,940
Exercise of warrants for cash, net of offering costs $ 10 500,051 500,061
Exercise of warrants for cash, net of offering costs (in Shares) 96,222        
Accretion of stock-based compensation in connection with stock option grants 17,445 17,445
Accumulated other comprehensive gain (loss) - short-term debt investments (1,140) (1,140)
Net loss (1,204,293) (1,204,293)
Balance at Jun. 30, 2025 $ 58 22,407,882 9,564 (17,500,421) 4,917,083
Balance (in Shares) at Jun. 30, 2025 576,742        
Balance at Dec. 31, 2025 $ 89 25,791,913 5,828 (19,492,389) 6,305,441
Balance (in Shares) at Dec. 31, 2025 887,886        
Accretion of stock-based compensation in connection with stock option grants 56,619 56,619
Accumulated other comprehensive gain (loss) - short-term debt investments 2,893 2,893
Issuance of common stock in exchange of future services $ 6 249,994 250,000
Issuance of common stock in exchange of future services (in Shares) 56,555        
Issuance of common stock in exchange of acquired technology $ 14 713,986 714,000
Issuance of common stock in exchange of acquired technology (in Shares) 140,000        
Net loss (1,647,117) (1,647,117)
Balance at Mar. 31, 2026 $ 109 26,812,512 8,721 (21,139,506) 5,681,836
Balance (in Shares) at Mar. 31, 2026 1,084,441        
Balance at Dec. 31, 2025 $ 89 25,791,913 5,828 (19,492,389) $ 6,305,441
Balance (in Shares) at Dec. 31, 2025 887,886        
Sale of common stock, net of offering costs and expenses of $406,044 (in Shares) 55,556       11,666,667
Net loss         $ (2,479,946)
Balance at Jun. 30, 2026 $ 113 26,851,682 6,830 (21,972,335) 4,886,290
Balance (in Shares) at Jun. 30, 2026 1,128,610        
Balance at Mar. 31, 2026 $ 109 26,812,512 8,721 (21,139,506) 5,681,836
Balance (in Shares) at Mar. 31, 2026 1,084,441        
Accretion of stock-based compensation in connection with stock option grants 39,174 39,174
Accumulated other comprehensive gain (loss) - short-term debt investments (1,891) (1,891)
Rounding shares from 1-for-15 reverse stock-split $ 4 (4)
Rounding shares from 1-for-15 reverse stock-split (in Shares) 44,169        
Net loss (832,829) (832,829)
Balance at Jun. 30, 2026 $ 113 $ 26,851,682 $ 6,830 $ (21,972,335) $ 4,886,290
Balance (in Shares) at Jun. 30, 2026 1,128,610